Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
|Podcasts|August 25, 2021
Urology Malpractice: Kenton H. Steele, Esq, discusses expert witnesses from the attorney perspective
Author(s)Urology Times staff
“Their opinions do need to be credible and be honest, but there is some component of being able to walk a line between providing a candid, unbiased opinion, and knowing that you are retained to represent a specific side in that case,” says Kenton H. Steele, Esq.
Advertisement
In this episode, Kenton H. Steele, Esq, discusses the role of expert witnesses in medical malpractice litigation and offers the attorney perspective on the qualities that make a good expert witness. Steele practices in the Columbus, Ohio, office of Reminger Co, LPA. He specializes in malpractice defense and insurance litigation.
Advertisement
Related to this article
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Pearls & Perspectives: Expanding Sexual Health Conversations Through Digital Media, With Wendy Brant
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
2
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
3
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
4
Closing Risk Stratification Gaps in Localized Prostate Cancer With AI
5